Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma studyL Khoja, E G Atenafu, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
ESMO Open|March 5, 2025
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARCC Cuvelier, M Brahmi, I Sobhani, et al.
ESMO Open|November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF<sup>V600</sup>-mutated melanomaJ Y Blay, C Cropet, S Mansard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 yearsJ Y Blay, C Tlemsani, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†C A Bellera, N Penel, M Ouali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2019
Surgery in reference centers improves survival of sarcoma patients: a nationwide studyJ-Y Blay, C Honoré, E Stoeckle, et al.
Pageof 11